$MCVT
Mill City Ventures III, Ltd

2021 Q4 Form 10-K Financial Statement

#000141057822000370 Filed on March 14, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 2020 Q4
Revenue $678.2K $1.301M $542.2K
YoY Change 25.09% 131.64% 1393.99%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $331.2K $1.355M $235.4K
YoY Change 40.68% 84.64% 42.85%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $0.00 $140.00
YoY Change -100.0% -100.0% -78.13%
% of Gross Profit
Operating Expenses $331.2K $1.355M $235.5K
YoY Change 40.6% 84.12% 42.37%
Operating Profit
YoY Change
Interest Expense -$30.12K $2.584M $1.301M
YoY Change -102.32% 33.2% -2944.6%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $316.9K $3.886M $1.607M
YoY Change -80.28% 55.31% -1019.07%
Income Tax $43.72K $1.055M $288.4K
% Of Pretax Income 13.79% 27.14% 17.94%
Net Earnings $273.2K $2.831M $1.319M
YoY Change -79.28% 27.9% -854.14%
Net Earnings / Revenue 40.28% 217.53% 243.24%
Basic Earnings Per Share $0.26
Diluted Earnings Per Share $56.97K $0.26 $121.7K
COMMON SHARES
Basic Shares Outstanding 10.79M 10.79M
Diluted Shares Outstanding 10.79M

Balance Sheet

Concept 2021 Q4 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.936M $1.936M $5.441M
YoY Change -64.41% -64.41% -32.55%
Cash & Equivalents $1.936M $5.441M
Short-Term Investments
Other Short-Term Assets $83.67K $83.67K $43.84K
YoY Change 90.85% 90.85% 38.91%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $2.594M $2.594M $5.820M
YoY Change -55.42% -55.42% -30.34%
LONG-TERM ASSETS
Property, Plant & Equipment $4.980K $4.980K $23.35K
YoY Change -78.67% -78.67% -45.56%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $2.449M $2.449M $6.668M
YoY Change -63.28% -63.28% 283.01%
Other Assets
YoY Change
Total Long-Term Assets $14.10M $14.10M $6.691M
YoY Change 110.78% 110.78% 275.12%
TOTAL ASSETS
Total Short-Term Assets $2.594M $2.594M $5.820M
Total Long-Term Assets $14.10M $14.10M $6.691M
Total Assets $16.70M $16.70M $12.51M
YoY Change 33.47% 33.47% 23.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $64.03K $64.03K $32.92K
YoY Change 94.51% 94.5% 31.67%
Accrued Expenses $1.275M $1.275M $39.78K
YoY Change 3104.25% 3104.25% -11.56%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.239M $3.239M $612.0K
YoY Change 429.21% 429.21% 774.54%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.239M $3.239M $612.0K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $3.284M $3.284M $870.0K
YoY Change 277.45% 277.45% 1143.38%
SHAREHOLDERS EQUITY
Retained Earnings -$1.160M -$1.160M
YoY Change 0.0%
Common Stock $10.79K $10.79K
YoY Change 0.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $13.41M $13.41M $11.64M
YoY Change
Total Liabilities & Shareholders Equity $16.70M $16.70M $12.51M
YoY Change 33.47% 33.47% 23.4%

Cashflow Statement

Concept 2021 Q4 2021 2020 Q4
OPERATING ACTIVITIES
Net Income $273.2K $2.831M $1.319M
YoY Change -79.28% 27.9% -854.14%
Depreciation, Depletion And Amortization $0.00 $0.00 $140.00
YoY Change -100.0% -100.0% -78.13%
Cash From Operating Activities -$579.3K -$1.886M $3.325M
YoY Change -117.42% -23.43% 49.59%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.079M -1.618M -4.650K
YoY Change 23105.16% 893.33%
NET CHANGE
Cash From Operating Activities -579.3K -1.886M 3.325M
Cash From Investing Activities
Cash From Financing Activities -1.079M -1.618M -4.650K
Net Change In Cash -1.658M -3.504M 3.320M
YoY Change -149.95% 33.45% 49.38%
FREE CASH FLOW
Cash From Operating Activities -$579.3K -$1.886M $3.325M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10789294
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10869054
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001425355
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei No Trading Symbol Flag
NoTradingSymbolFlag
true
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10789294
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10869054
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10790413
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10785913
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
814-00991
CY2021 dei Entity Registrant Name
EntityRegistrantName
MILL CITY VENTURES III, LTD.
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MN
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
90-0316651
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
1907 Wayzata Blvd
CY2021 dei Entity Address Address Line2
EntityAddressAddressLine2
#205
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Wayzata
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55391
CY2021 dei City Area Code
CityAreaCode
952
CY2021 dei Local Phone Number
LocalPhoneNumber
479-1923
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10673014
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1159665
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1159665
CY2021 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
false
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
20272879
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10790413
CY2021 dei Auditor Firm
AuditorFirmId
542
CY2021 dei Auditor Name
AuditorName
Boulay PLLP
CY2021 dei Auditor Location
AuditorLocation
Minneapolis, Minnesota
CY2021Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
14098675
CY2020Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
6667897
CY2021Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
13933057
CY2020Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
4968576
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1936148
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5440579
CY2021Q4 us-gaap Notes Receivable Net
NotesReceivableNet
250000
CY2020Q4 us-gaap Notes Receivable Net
NotesReceivableNet
250000
CY2021Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
83674
CY2020Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
43838
CY2020Q4 mcvt Receivable For Sale Of Investment
ReceivableForSaleOfInvestment
19313
CY2021Q4 mcvt Interest And Dividends Receivable
InterestAndDividendsReceivable
324350
CY2020Q4 mcvt Interest And Dividends Receivable
InterestAndDividendsReceivable
65911
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4984
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
23345
CY2021Q4 us-gaap Assets
Assets
16697831
CY2020Q4 us-gaap Assets
Assets
12510883
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
64028
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
32917
CY2021Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
100
CY2020Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
539296
CY2021Q4 mcvt Payable For Purchase Of Investments
PayableForPurchaseOfInvestments
1900000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
5654
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
26061
CY2021Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
1269000
CY2020Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
13722
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
45000
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
258000
CY2021Q4 us-gaap Liabilities
Liabilities
3283782
CY2020Q4 us-gaap Liabilities
Liabilities
869996
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10790413
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10785913
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
10790
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
10786
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10694163
CY2021Q4 us-gaap Investment Company Distributable Earnings Loss Accumulated Ordinary Income Loss
InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss
-1877667
CY2020Q4 us-gaap Investment Company Distributable Earnings Loss Accumulated Ordinary Income Loss
InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss
-2124419
CY2021Q4 mcvt Investment Company Distributable Earnings Loss Accumulated Capital Gain Loss
InvestmentCompanyDistributableEarningsLossAccumulatedCapitalGainLoss
5580810
CY2020Q4 mcvt Investment Company Distributable Earnings Loss Accumulated Capital Gain Loss
InvestmentCompanyDistributableEarningsLossAccumulatedCapitalGainLoss
2541850
CY2021Q4 us-gaap Investment Company Distributable Earnings Loss Accumulated Appreciation Depreciation
InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation
165618
CY2020Q4 us-gaap Investment Company Distributable Earnings Loss Accumulated Appreciation Depreciation
InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation
1699321
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
13414049
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
11640887
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16697831
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12510883
CY2021Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
1.24
CY2020Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
1.08
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
2656201
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
1282175
CY2020 us-gaap Investment Income Dividend
InvestmentIncomeDividend
15462
CY2021 us-gaap Gross Investment Income Operating
GrossInvestmentIncomeOperating
2656201
CY2020 us-gaap Gross Investment Income Operating
GrossInvestmentIncomeOperating
1297637
CY2021 mcvt Professional Fees Net
ProfessionalFeesNet
453440
CY2020 mcvt Professional Fees Net
ProfessionalFeesNet
175612
CY2021 us-gaap Labor And Related Expense
LaborAndRelatedExpense
556432
CY2020 us-gaap Labor And Related Expense
LaborAndRelatedExpense
301494
CY2021 us-gaap General Insurance Expense
GeneralInsuranceExpense
108165
CY2020 us-gaap General Insurance Expense
GeneralInsuranceExpense
85237
CY2021 us-gaap Occupancy Net
OccupancyNet
66459
CY2020 us-gaap Occupancy Net
OccupancyNet
66307
CY2021 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
120000
CY2020 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
90000
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2071
CY2021 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
50255
CY2020 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
15069
CY2021 us-gaap Operating Expenses
OperatingExpenses
1354751
CY2020 us-gaap Operating Expenses
OperatingExpenses
735790
CY2021 us-gaap Net Investment Income
NetInvestmentIncome
1301450
CY2020 us-gaap Net Investment Income
NetInvestmentIncome
561847
CY2021 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
4118001
CY2020 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
5330
CY2021 mcvt Net Change In Unrealized Appreciation Depreciation On Investments
NetChangeInUnrealizedAppreciationDepreciationOnInvestments
-1533703
CY2020 mcvt Net Change In Unrealized Appreciation Depreciation On Investments
NetChangeInUnrealizedAppreciationDepreciationOnInvestments
1934794
CY2021 us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
2584298
CY2020 us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
1940124
CY2021 mcvt Investment Company Net Assets Period Increase Decrease Before Income Taxes
InvestmentCompanyNetAssetsPeriodIncreaseDecreaseBeforeIncomeTaxes
3885748
CY2020 mcvt Investment Company Net Assets Period Increase Decrease Before Income Taxes
InvestmentCompanyNetAssetsPeriodIncreaseDecreaseBeforeIncomeTaxes
2501971
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1054698
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
288401
CY2021 mcvt Investment Company Net Increase Decrease In Net Assets From Operations
InvestmentCompanyNetIncreaseDecreaseInNetAssetsFromOperations
2831050
CY2020 mcvt Investment Company Net Increase Decrease In Net Assets From Operations
InvestmentCompanyNetIncreaseDecreaseInNetAssetsFromOperations
2213570
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10789294
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-2626077
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5440579
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8066656
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
61000
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2071
CY2021 mcvt Income Tax Payable Operating Activities
IncomeTaxPayableOperatingActivities
-1255278
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-213000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
271722
CY2021 mcvt Common Shares Issued As Consideration For Expense Payment
CommonSharesIssuedAsConsiderationForExpensePayment
15403
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
21475
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-5197
CY2021 us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
258439
CY2020 us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
59411
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10869054
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
11640887
CY2021 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
21153
CY2021 mcvt Cash Dividend Declared
CashDividendDeclared
1079041
CY2021 us-gaap Undistributed Earnings
UndistributedEarnings
246752
CY2021 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
4118001
CY2021 mcvt Net Change In Unrealized Appreciation Depreciation On Investments
NetChangeInUnrealizedAppreciationDepreciationOnInvestments
-1533703
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
13414049
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
10068533
CY2020 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
162920
CY2020 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
61000
CY2020 mcvt Cash Dividend Declared
CashDividendDeclared
539296
CY2020 us-gaap Undistributed Earnings
UndistributedEarnings
273446
CY2020 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
5330
CY2020 mcvt Net Change In Unrealized Appreciation Depreciation On Investments
NetChangeInUnrealizedAppreciationDepreciationOnInvestments
1934794
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
11640887
CY2021 mcvt Net Increase Decrease In Net Assets From Operations
NetIncreaseDecreaseInNetAssetsFromOperations
-2831050
CY2020 mcvt Net Increase Decrease In Net Assets From Operations
NetIncreaseDecreaseInNetAssetsFromOperations
-2213570
CY2021 mcvt Net Change In Unrealized Appreciation Depreciation On Investments
NetChangeInUnrealizedAppreciationDepreciationOnInvestments
-1533703
CY2020 mcvt Net Change In Unrealized Appreciation Depreciation On Investments
NetChangeInUnrealizedAppreciationDepreciationOnInvestments
1934794
CY2021 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
4118001
CY2020 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
5330
CY2021 mcvt Payments To Purchase Investments
PaymentsToPurchaseInvestments
27029292
CY2020 mcvt Payments To Purchase Investments
PaymentsToPurchaseInvestments
9405802
CY2021 mcvt Proceeds From Sale Of Investments
ProceedsFromSaleOfInvestments
22188562
CY2020 mcvt Proceeds From Sale Of Investments
ProceedsFromSaleOfInvestments
6418926
CY2021 mcvt Increase Decrease In Receivable For Investment Sales
IncreaseDecreaseInReceivableForInvestmentSales
-19313
CY2020 mcvt Increase Decrease In Receivable For Investment Sales
IncreaseDecreaseInReceivableForInvestmentSales
19313
CY2021 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
10804
CY2020 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-10993
CY2021 mcvt Increase Decrease In Payable For Investment Purchase
IncreaseDecreaseInPayableForInvestmentPurchase
1900000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1886094
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2463157
CY2020 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
162920
CY2021 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1618337
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1618337
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-162920
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-3504431
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1936148
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5440579
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
32398
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
16679
CY2021 us-gaap Stock Issued1
StockIssued1
5750
CY2020 mcvt Cash Dividends Declared To Common Stock Shareholders
CashDividendsDeclaredToCommonStockShareholders
539296
CY2021Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
13933057
CY2021Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
14098675
CY2021Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
1.0510
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1936148
CY2021Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
1936148
CY2021 mcvt Cash And Cash Equivalents Percent Of Net Assets
CashAndCashEquivalentsPercentOfNetAssets
0.1443
CY2021Q4 mcvt Investments And Cash Cost
InvestmentsAndCashCost
15869205
CY2021Q4 mcvt Investments And Cash Fair Value
InvestmentsAndCashFairValue
16034823
CY2021 mcvt Investments And Cash Percentage Of Net Assets
InvestmentsAndCashPercentageOfNetAssets
1.1953
CY2020Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
4968576
CY2020Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
6667897
CY2020Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.5730
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5440579
CY2020Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
5440579
CY2020 mcvt Cash And Cash Equivalents Percent Of Net Assets
CashAndCashEquivalentsPercentOfNetAssets
0.4674
CY2020Q4 mcvt Investments And Cash Cost
InvestmentsAndCashCost
10409155
CY2020Q4 mcvt Investments And Cash Fair Value
InvestmentsAndCashFairValue
12108476
CY2020 mcvt Investments And Cash Percentage Of Net Assets
InvestmentsAndCashPercentageOfNetAssets
1.0404
CY2021 mcvt Maximum Percentage Of Total Assets Investment Securities
MaximumPercentageOfTotalAssetsInvestmentSecurities
0.40
CY2021 mcvt Investment Company Net Increase Decrease In Net Assets From Operations
InvestmentCompanyNetIncreaseDecreaseInNetAssetsFromOperations
2831050
CY2020 mcvt Investment Company Net Increase Decrease In Net Assets From Operations
InvestmentCompanyNetIncreaseDecreaseInNetAssetsFromOperations
2213570
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10789294
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10869054
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
CY2021 mcvt Number Of Non Cancelable Operating Leases
NumberOfNonCancelableOperatingLeases
2
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.045
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y
CY2021 us-gaap Lease Cost
LeaseCost
66459
CY2020 us-gaap Lease Cost
LeaseCost
66307
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
19116
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
19116
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
17613
CY2020 us-gaap Variable Lease Cost
VariableLeaseCost
17461
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
29730
CY2020 us-gaap Short Term Lease Cost
ShortTermLeaseCost
29730
CY2021 us-gaap Lease Cost
LeaseCost
66459
CY2020 us-gaap Lease Cost
LeaseCost
66307
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4984
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
5654
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5654
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
5449
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
5449
CY2021Q4 mcvt Lease Payment Plus Interest
LeasePaymentPlusInterest
205
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
5654
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10790413
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10785913
CY2021 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
4500
CY2020Q4 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
400000
CY2021Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
13933057
CY2021 mcvt Percentage Of Amortized Cost
PercentageOfAmortizedCost
1.000
CY2021Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
14098675
CY2021 mcvt Percentage Of Fair Value
PercentageOfFairValue
1.000
CY2020Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
4968576
CY2020 mcvt Percentage Of Amortized Cost
PercentageOfAmortizedCost
1.000
CY2020Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
6667897
CY2020 mcvt Percentage Of Fair Value
PercentageOfFairValue
1.000
CY2021Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
14098675
CY2021 mcvt Percentage Of Fair Value
PercentageOfFairValue
1.000
CY2020Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
6667897
CY2020 mcvt Percentage Of Fair Value
PercentageOfFairValue
1.000
CY2021Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
14098675
CY2020Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
6667897
CY2021 us-gaap Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
0
CY2020 us-gaap Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
0
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2021 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
1
CY2021 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.05
CY2021 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
11250
CY2020 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
10550
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
909530
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
357168
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
16679
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-212000
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
258000
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
13722
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1054698
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
288401
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
1017417
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
716966
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-446000
CY2021 mcvt Effective Income Tax Rate Reconciliation Provision To Return Reconciliation Amount
EffectiveIncomeTaxRateReconciliationProvisionToReturnReconciliationAmount
-14743
CY2020 mcvt Effective Income Tax Rate Reconciliation Provision To Return Reconciliation Amount
EffectiveIncomeTaxRateReconciliationProvisionToReturnReconciliationAmount
21657
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-1976
CY2020 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-4222
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1054698
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
288401
CY2020Q4 mcvt Operating Loss Carryforwards Not Subject To Expiration
OperatingLossCarryforwardsNotSubjectToExpiration
350000
CY2020Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1330000
CY2021Q4 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
46552
CY2020Q4 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
488419
CY2021Q4 mcvt Deferred Tax Assets Depreciation
DeferredTaxAssetsDepreciation
2458
CY2020Q4 mcvt Deferred Tax Assets Depreciation
DeferredTaxAssetsDepreciation
3002
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
180460
CY2020Q4 mcvt Deferred Tax Assets Tax Credit Carryforwards Research Developments And Foreign
DeferredTaxAssetsTaxCreditCarryforwardsResearchDevelopmentsAndForeign
46957
CY2021Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
906
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
45000
CY2020Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
258000
CY2020Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
1.08
CY2019Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
0.91
CY2018Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
1.02
CY2017Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
0.87
CY2016Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
0.77
CY2021 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.12
CY2020 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.05
us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
-0.06
us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
-0.05
us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
-0.05
CY2017Q3 us-gaap Assets Net
AssetsNet
9629215
CY2021Q4 mcvt Average Assets Net
AverageAssetsNet
13155207
CY2020Q4 mcvt Average Assets Net
AverageAssetsNet
10504563
CY2019Q3 mcvt Average Assets Net
AverageAssetsNet
11473535
CY2018Q3 mcvt Average Assets Net
AverageAssetsNet
10341702
CY2021 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
0.24
CY2020 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
0.18
us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
0.00
us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
0.20
us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
0.11
CY2021 mcvt Investment Company Provision For Income Taxes Per Share
InvestmentCompanyProvisionForIncomeTaxesPerShare
-0.10
CY2020 mcvt Investment Company Provision For Income Taxes Per Share
InvestmentCompanyProvisionForIncomeTaxesPerShare
-0.02
mcvt Investment Company Provision For Income Taxes Per Share
InvestmentCompanyProvisionForIncomeTaxesPerShare
0.00
mcvt Investment Company Provision For Income Taxes Per Share
InvestmentCompanyProvisionForIncomeTaxesPerShare
0.00
mcvt Investment Company Provision For Income Taxes Per Share
InvestmentCompanyProvisionForIncomeTaxesPerShare
0.00
CY2021 mcvt Investment Company Stock Based Compensation
InvestmentCompanyStockBasedCompensation
0.00
CY2020 mcvt Investment Company Stock Based Compensation
InvestmentCompanyStockBasedCompensation
-0.01
mcvt Investment Company Stock Based Compensation
InvestmentCompanyStockBasedCompensation
0.00
mcvt Investment Company Stock Based Compensation
InvestmentCompanyStockBasedCompensation
0.00
mcvt Investment Company Stock Based Compensation
InvestmentCompanyStockBasedCompensation
0.00
CY2021 mcvt Investment Company Repurchase Of Common Stock Per Share
InvestmentCompanyRepurchaseOfCommonStockPerShare
0.00
CY2020 mcvt Investment Company Repurchase Of Common Stock Per Share
InvestmentCompanyRepurchaseOfCommonStockPerShare
0.02
mcvt Investment Company Repurchase Of Common Stock Per Share
InvestmentCompanyRepurchaseOfCommonStockPerShare
0.00
mcvt Investment Company Repurchase Of Common Stock Per Share
InvestmentCompanyRepurchaseOfCommonStockPerShare
0.00
mcvt Investment Company Repurchase Of Common Stock Per Share
InvestmentCompanyRepurchaseOfCommonStockPerShare
0.04
CY2021 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
0.10
CY2020 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
0.05
us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
0.05
us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
0.00
us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
0.00
CY2021Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
1.24
CY2020Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
1.08
CY2019Q3 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
0.91
CY2018Q3 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
1.02
CY2017Q3 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
0.87
CY2021Q4 mcvt Market Value Of Investments Per Share
MarketValueOfInvestmentsPerShare
1.31
CY2020Q4 mcvt Market Value Of Investments Per Share
MarketValueOfInvestmentsPerShare
0.62
CY2019Q3 mcvt Market Value Of Investments Per Share
MarketValueOfInvestmentsPerShare
0.16
CY2018Q3 mcvt Market Value Of Investments Per Share
MarketValueOfInvestmentsPerShare
0.90
CY2017Q3 mcvt Market Value Of Investments Per Share
MarketValueOfInvestmentsPerShare
0.65
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10790413
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10785913
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11067402
CY2018Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11067402
CY2017Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11067402
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10789294
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10869054
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11067402
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11067402
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11863392
CY2021Q4 us-gaap Assets Net
AssetsNet
13414049
CY2020Q4 us-gaap Assets Net
AssetsNet
11640887
CY2019Q3 us-gaap Assets Net
AssetsNet
10068533
CY2018Q3 us-gaap Assets Net
AssetsNet
11278889
CY2017Q3 mcvt Average Assets Net
AverageAssetsNet
9444440
CY2021 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.2407
CY2020 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.2308
us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.0588
us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.1724
us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.0779
CY2021 mcvt Investment Company Portfolio Turnover Rate
InvestmentCompanyPortfolioTurnoverRate
168.67
CY2020 mcvt Investment Company Portfolio Turnover Rate
InvestmentCompanyPortfolioTurnoverRate
61.11
mcvt Investment Company Portfolio Turnover Rate
InvestmentCompanyPortfolioTurnoverRate
7.63
mcvt Investment Company Portfolio Turnover Rate
InvestmentCompanyPortfolioTurnoverRate
26.93
mcvt Investment Company Portfolio Turnover Rate
InvestmentCompanyPortfolioTurnoverRate
35.03
CY2021 us-gaap Investment Company Expense Ratio After Incentive Allocation
InvestmentCompanyExpenseRatioAfterIncentiveAllocation
0.1030
CY2020 us-gaap Investment Company Expense Ratio After Incentive Allocation
InvestmentCompanyExpenseRatioAfterIncentiveAllocation
0.0716
us-gaap Investment Company Expense Ratio After Incentive Allocation
InvestmentCompanyExpenseRatioAfterIncentiveAllocation
0.0727
us-gaap Investment Company Expense Ratio After Incentive Allocation
InvestmentCompanyExpenseRatioAfterIncentiveAllocation
0.0659
us-gaap Investment Company Expense Ratio After Incentive Allocation
InvestmentCompanyExpenseRatioAfterIncentiveAllocation
0.0730
CY2021 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0989
CY2020 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0535
us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
-0.0586
us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
-0.0513
us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
-0.0545
CY2021 mcvt Investment Company Realized Gains Losses Ratio
InvestmentCompanyRealizedGainsLossesRatio
31.30
CY2020 mcvt Investment Company Realized Gains Losses Ratio
InvestmentCompanyRealizedGainsLossesRatio
0.05
mcvt Investment Company Realized Gains Losses Ratio
InvestmentCompanyRealizedGainsLossesRatio
28.35
mcvt Investment Company Realized Gains Losses Ratio
InvestmentCompanyRealizedGainsLossesRatio
-5.62
mcvt Investment Company Realized Gains Losses Ratio
InvestmentCompanyRealizedGainsLossesRatio
5.71

Files In Submission

Name View Source Status
0001410578-22-000370-index-headers.html Edgar Link pending
0001410578-22-000370-index.html Edgar Link pending
0001410578-22-000370.txt Edgar Link pending
0001410578-22-000370-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
mcvt-20211231.xsd Edgar Link pending
mcvt-20211231x10k.htm Edgar Link pending
mcvt-20211231x10k001.jpg Edgar Link pending
mcvt-20211231x10k_htm.xml Edgar Link completed
mcvt-20211231xex31d1.htm Edgar Link pending
mcvt-20211231xex31d2.htm Edgar Link pending
mcvt-20211231xex32d2.htm Edgar Link pending
mcvt-20211231_cal.xml Edgar Link unprocessable
mcvt-20211231_def.xml Edgar Link unprocessable
mcvt-20211231_lab.xml Edgar Link unprocessable
mcvt-20211231_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending